{
    "Trade/Device Name(s)": [
        "SYNCHRON\u00ae Systems Enzymatic Creatinine (CR-E) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K091742",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071283"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY"
    ],
    "Summary Letter Date": "August 14, 2009",
    "Summary Letter Received Date": "June 16, 2009",
    "Submission Date": "June 11, 2009",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON LX",
        "UniCel DxC 600/800",
        "SYNCHRON CX PRO Clinical Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic method",
        "Photometric end-point reaction"
    ],
    "Methodologies": [
        "Enzymatic measurement"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems Enzymatic Creatinine (CR-E) Reagent for quantitation of creatinine in serum, plasma, and urine using enzymatic method",
    "Indications for Use Summary": "Quantitative determination of creatinine concentration in human serum, plasma, or urine (urine not available on SYNCHRON CX PRO Systems), used in diagnosis and treatment of renal diseases and monitoring renal dialysis",
    "fda_folder": "Clinical Chemistry"
}